Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)

Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)

Introduction Scabies is a significant contributor to global morbidity, affecting approximately 200 million people at any time. Scabies is endemic in many resource-limited tropical settings. Bacterial skin infection (impetigo) frequently complicates scabies infestation in these settings. Community-wi...

Full description

Bibliographic Details
Main Authors: John Kaldor, Oliver Sokana, Tibor Schuster, Ross Andrews, Susanna J Lake, Sophie L Phelan, Daniel Engelman, Titus Nasi, Dickson Boara, Christina Gorae, Anneke C Grobler, Millicent H Osti, Margot J Whitfeld, Lucia Romani, Andrew Steer
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/8/e037305.full

Internet

https://bmjopen.bmj.com/content/10/8/e037305.full

Similar Items